Exclusive: Myriad Genetics Discusses The Growing Market In Genetic Testing
October 26, 2016 at 10:20 AM EDT
Myriad Genetics, Inc. (NASDAQ: MYGN) is a molecular diagnostic company engaged in the development and marketing of transformative ...